Fundacion Respirar - Centro Médico Dra. De Salvo

Ciudad Autonoma de Buenos Aires (caba)

0 studies enrolling now · 1 studies all time

What they study most

Idiopathic Pulmonary Fibrosis

Studies at this site

• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early